Bentham Science Logo

Track Your Manuscript:


Current Signal Transduction Therapy

Volume 15, 3 Issues, 2020
ISSN: 2212-389X (Online)
ISSN: 1574-3624 (Print)
This journal supports open access

Contents

Current Signal Transduction Therapy, Volume 6 - Number 2









HGF-Antagonists: Structure, Activities, and Anti-cancer Approach

, 6(2): 191 - 199

Katsuya Sakai, Takahiro Nakamura, Takayoshi Kinoshita, Toshikazu Nakamura and Kunio Matsumoto


DOI: 10.2174/157436211795659964




HGF as Angiogenic Factor and Therapeutic Approach

, 6(2): 221 - 227

Yoshiaki Taniyama, Yasushi Takeya, Junya Azuma, Kazuma Iekushi, Fumihiro Sanada, Hiroshi Kusunoki, Keita Okayama, Nobutaka Koibuchi, Hiromi Rakugi and Ryuichi Morishita


DOI: 10.2174/157436211795660016


HGF-MET in Resistance to EGFR Tyrosine Kinase Inhibitors in Lung Cancer

, 6(2): 228 - 233

Seiji Yano, Wei Wang, Qi Li, Tadaaki Yamada, Shinji Takeuchi, Kunio Matsumoto, Yasuhiko Nishioka and Saburo Sone


DOI: 10.2174/157436211795659928









Editor-in-Chief

Jingxuan Yang
The University of Oklahoma Health Science Center
Oklahoma City, OK
(USA)

Biography
View Full Editorial Board

COPE Compliant

Journal History

Current Signal Transduction Therapy was launched in 2006. Dr. Jingxuan Yang serves as the Editor-in-Chief of the journal.

Advertisement

PLANNING YOUR RESEARCH TO PUBLISH IN HIGH IMPACT JOURNALSCovid Resource Center

Related Journals

Related eBooks

eBooks Catalog